Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations
Daniela Cesana, … , Luigi Naldini, Eugenio Montini
Daniela Cesana, … , Luigi Naldini, Eugenio Montini
Published April 23, 2012
Citation Information: J Clin Invest. 2012;122(5):1667-1676. https://doi.org/10.1172/JCI62189.
View: Text | PDF
Research Article Article has an altmetric score of 8

Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations

  • Text
  • PDF
Abstract

Gamma-retroviral/lentiviral vectors (γRV/LV) with self-inactivating (SIN) long terminal repeats (LTRs) and internal moderate cellular promoters pose a reduced risk of insertional mutagenesis when compared with vectors with active LTRs. Yet, in a recent LV-based clinical trial for β-thalassemia, vector integration within the HMGA2 gene induced the formation of an aberrantly spliced mRNA form that appeared to cause clonal dominance. Using a method that we developed, cDNA linear amplification-mediated PCR, in combination with high-throughput sequencing, we conducted a whole transcriptome analysis of chimeric LV-cellular fusion transcripts in transduced human lymphoblastoid cells and primary hematopoietic stem/progenitor cells. We observed a surprising abundance of read-through transcription originating outside and inside the provirus and identified the vector sequences contributing to the aberrant splicing process. We found that SIN LV has a sharply reduced propensity to engage in aberrant splicing compared with that of vectors carrying active LTRs. Moreover, by recoding the identified vector splice sites, we reduced residual read-through transcription and demonstrated an effective strategy for improving vectors. Characterization of the mechanisms and genetic features underlying vector-induced aberrant splicing will enable the generation of safer vectors, with low impact on the cellular transcriptome.

Authors

Daniela Cesana, Jacopo Sgualdino, Laura Rudilosso, Stefania Merella, Luigi Naldini, Eugenio Montini

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Total
Citations: 4 4 5 6 1 2 6 4 6 4 7 10 4 63
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (63)

Title and authors Publication Year
Effects of an indole derivative on cell proliferation, transfection, and alternative splicing in production of lentiviral vectors by transient co-transfection
Mier NC, Roper DK
PloS one 2024
Mechanisms and Delivery of tRNA Therapeutics
Ward C, Beharry A, Tennakoon R, Rozik P, Wilhelm SD, Heinemann IU, O\u2019Donoghue P
Chemical Reviews 2024
Optimization of a lentivirus-mediated gene therapy targeting HIV-1 RNA to eliminate HIV-1-infected cells
Buckingham AB, Ho S, Knops-Mckim F, Ingemarsdotter CK, Lever AM
Molecular Therapy. Nucleic Acids 2024
Balancing efficacy and safety in lentiviral vector-mediated hematopoietic stem cell gene therapy
Montini E, Naldini L, Booth C, Kohn DB, Aiuti A
Molecular Therapy 2024
CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells
Brault J, Liu T, Liu S, Lawson A, Choi U, Kozhushko N, Bzhilyanskaya V, Pavel-Dinu M, Meis RJ, Eckhaus MA, Burkett SS, Bosticardo M, Kleinstiver BP, Notarangelo LD, Lazzarotto CR, Tsai SQ, Wu X, Dahl GA, Porteus MH, Malech HL, De Ravin SS
Frontiers in immunology 2023
Editorial: The relevance of molecular mechanisms in HIV-1 latency and reactivation from latency
Pasternak AO, Rohr O, Van Lint C, Kula-Pacurar A
Frontiers in Cellular and Infection Microbiology 2023
Correcting inborn errors of immunity: From viral mediated gene addition to gene editing
Castiello MC, Ferrari S, Villa A
Seminars in Immunology 2023
Emerging Gene Therapy Technologies for Retinal Ganglion Cell Neuroprotection
Camacho DK, Go CC, Chaqour B, Shindler KS, Ross AG
Journal of Neuro-Ophthalmology 2023
Detection of Chimeric Cellular: HIV mRNAs Generated Through Aberrant Splicing in HIV-1 Latently Infected Resting CD4+ T Cells.
Lee MY, Khoury G, Olshansky M, Sonza S, Carter GP, McMahon J, Stinear TP, Turner SJ, Lewin SR, Purcell DFJ
Frontiers in Cellular and Infection Microbiology 2022
Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency
De Ravin SS, Liu S, Sweeney CL, Brault J, Whiting-Theobald N, Ma M, Liu T, Choi U, Lee J, O\u2019Brien SA, Quackenbush P, Estwick T, Karra A, Docking E, Kwatemaa N, Guo S, Su L, Sun Z, Zhou S, Puck J, Cowan MJ, Notarangelo LD, Kang E, Malech HL, Wu X
Nature Communications 2022
Evaluating the state of the science for adeno-associated virus integration: An integrated perspective
Sabatino DE, Bushman FD, Chandler RJ, Crystal RG, Davidson BL, Dolmetsch R, Eggan KC, Gao G, Gil-Farina I, Kay MA, McCarty DM, Montini E, Ndu A, Yuan J
Molecular Therapy 2022
Aberrant splicing events caused by insertion of genes of interest into expression vectors
Cheng Y, Kang XZ, Chan P, Ye ZW, Chan CP, Jin DY
International journal of biological sciences 2022
Determinants of Retroviral Integration and Implications for Gene Therapeutic MLV—Based Vectors and for a Cure for HIV-1 Infection
Pellaers E, Bhat A, Christ F, Debyser Z
Viruses 2022
T-Helper Cells: Methods and Protocols
F Annunziato, L Maggi, A Mazzoni
2021
Viral vector platforms within the gene therapy landscape
JT Bulcha, Y Wang, H Ma, PW Tai, G Gao
Signal Transduction and Targeted Therapy 2021
HIV-based lentiviral vectors: Origin and sequence differences
NM Johnson, AF Alvarado, TN Moffatt, JM Edavettal, TA Swaminathan, SE Braun
Molecular Therapy — Methods & Clinical Development 2021
Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
V Poletti, F Mavilio
Viruses 2021
The Splice of Life: Does RNA Processing Have a Role in HIV-1 Persistence?
AO Pasternak, B Berkhout
Viruses 2021
Overexpression of lncRNAs with endogenous lengths and functions using a lncRNA delivery system based on transposon
Y Zhang, YX Huang, X Jin, J Chen, L Peng, DL Wang, Y Li, XY Yao, JY Liao, JH He, KS Hu, D Lu, Y Guo, D Yin
Journal of nanobiotechnology 2021
AAV-BASED GENE THERAPY FOR LIFE-LONG CORRECTION OF GENETIC DISEASE
C Brommel, A Cooney, PL Sinn
Human Gene Therapy 2020
Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque
DA Espinoza, X Fan, D Yang, SF Cordes, LL Truitt, KR Calvo, IM Yabe, S Demirci, KJ Hope, SG Hong, A Krouse, M Metzger, A Bonifacino, R Lu, N Uchida, JF Tisdale, X Wu, SS DeRavin, HL Malech, RE Donahue, C Wu, CE Dunbar
Molecular Therapy 2019
Viral modulation of cellular RNA alternative splicing: A new key player in virus–host interactions?
S Boudreault, P Roy, G Lemay, M Bisaillon
Wiley interdisciplinary reviews. RNA 2019
The role of integration and clonal expansion in HIV infection: live long and prosper
EM Anderson, F Maldarelli
Retrovirology 2018
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency
V Poletti, S Charrier, G Corre, B Gjata, A Vignaud, F Zhang, M Rothe, A Schambach, HB Gaspar, AJ Thrasher, F Mavilio
Molecular Therapy — Methods & Clinical Development 2018
Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes
VM Bii, CP Collins, JD Hocum, GD Trobridge
Oncotarget 2018
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia
MR Lidonnici, Y Paleari, F Tiboni, G Mandelli, C Rossi, M Vezzoli, A Aprile, CW Lederer, A Ambrosi, F Chanut, F Sanvito, A Calabria, V Poletti, F Mavilio, E Montini, L Naldini, P Cristofori, G Ferrari
Molecular Therapy — Methods & Clinical Development 2018
Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies
K Bhukhai, E de Dreuzy, M Giorgi, C Colomb, O Negre, M Denaro, B Gillet-Legrand, J Cheuzeville, A Paulard, H Trebeden-Negre, S Borwornpinyo, K Sii-Felice, L Maouche, JD Down, P Leboulch, E Payen
Molecular Therapy 2018
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease
V Poletti, F Urbinati, S Charrier, G Corre, RP Hollis, BC Fernandez, S Martin, M Rothe, A Schambach, DB Kohn, F Mavilio
Molecular Therapy — Methods & Clinical Development 2018
An RNA-targeted therapy for dystrophic epidermolysis bullosa
P Peking, U Koller, B Duarte, R Murillas, S Wolf, T Maetzig, M Rothe, T Kocher, M García, G Brachtl, A Schambach, F Larcher, J Reichelt, JW Bauer, EM Murauer
Nucleic Acids Research 2017
Engineering of PEDF-Expressing Primary Pigment Epithelial Cells by the SB Transposon System Delivered by pFAR4 Plasmids
G Thumann, N Harmening, C Prat-Souteyrand, C Marie, M Pastor, A Sebe, C Miskey, LD Hurst, S Diarra, M Kropp, P Walter, D Scherman, Z Ivics, Z Izsvák, S Johnen
Molecular Therapy - Nucleic Acids 2017
HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells
D Cesana, FR de Sio, L Rudilosso, P Gallina, A Calabria, S Beretta, I Merelli, E Bruzzesi, L Passerini, S Nozza, E Vicenzi, G Poli, S Gregori, G Tambussi, E Montini
Nature Communications 2017
Targeting Splicing in the Treatment of Human Disease
M Suñé-Pou, S Prieto-Sánchez, S Boyero-Corral, C Moreno-Castro, YE Yousfi, J Suñé-Negre, C Hernández-Munain, C Suñé
Genes & development 2017
Pervasive supply of therapeutic lysosomal enzymes in the CNS of normal and Krabbe‐affected non‐human primates by intracerebral lentiviral gene therapy
V Meneghini, A Lattanzi, L Tiradani, G Bravo, F Morena, F Sanvito, A Calabria, J Bringas, JM FisherPerkins, JP Dufour, KC Baker, C Doglioni, E Montini, BA Bunnell, K Bankiewicz, S Martino, L Naldini, A Gritti
EMBO Molecular Medicine 2016
Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector
NP Sweeney, C Regan, J Liu, A Galleu, F Dazzi, D Lindemann, CA Rupar, MO McClure
Molecular Therapy 2016
Towards a Safer, More Randomized Lentiviral Vector Integration Profile Exploring Artificial LEDGF Chimeras
LS Vranckx, J Demeulemeester, Z Debyser, R Gijsbers, Y Ikeda
PloS one 2016
A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance
EM Everson, ME Olzsko, DJ Leap, JD Hocum, GD Trobridge
Molecular Therapy — Methods & Clinical Development 2016
Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors
V Bii, G Trobridge
Cancers 2016
Targeted approaches to induce immune tolerance for Pompe disease therapy
PA Doerfler, S Nayak, M Corti, L Morel, RW Herzog, BJ Byrne
Molecular Therapy — Methods & Clinical Development 2016
Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors
P Hu, Y Li, MS Sands, T McCown, T Kafri
Molecular Therapy — Methods & Clinical Development 2015
Gene activity in primary T cells infected with HIV89.6: intron retention and induction of genomic repeats
S Sherrill-Mix, KE Ocwieja, FD Bushman
Retrovirology 2015
Gene therapy: progress and predictions
M Collins, A Thrasher
Proceedings of the Royal Society B: Biological Sciences 2015
A minimal ubiquitous chromatin opening element (UCOE) effectively prevents silencing of juxtaposed heterologous promoters by epigenetic remodeling in multipotent and pluripotent stem cells
U Muller-Kuller, M Ackermann, S Kolodziej, C Brendel, J Fritsch, N Lachmann, H Kunkel, J Lausen, A Schambach, T Moritz, M Grez
Nucleic Acids Research 2015
Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo
D Cesana, M Ranzani, M Volpin, C Bartholomae, C Duros, A Artus, S Merella, F Benedicenti, LS Sergi, F Sanvito, C Brombin, A Nonis, CD Serio, C Doglioni, C Kalle, M Schmidt, O Cohen-Haguenauer, L Naldini, E Montini
Molecular Therapy 2014
Concise Review: Lessons Learned From Clinical Trials of Gene Therapy in Monogenic Immunodeficiency Diseases
DA Williams, AJ Thrasher
Stem Cells Translational Medicine 2014
Integration Site and Clonal Expansion in Human Chronic Retroviral Infection and Gene Therapy
H Niederer, C Bangham
Viruses 2014
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells
G Turchiano, MC Latella, A Gogol-Döring, C Cattoglio, F Mavilio, Z Izsvák, Z Ivics, A Recchia, SD Fugmann
PloS one 2014
Efficient transduction of LEDGF/p75 mutant cells by complementary gain-of-function HIV-1 integrase mutant viruses
H Wang, MC Shun, X Li, FD Nunzio, S Hare, P Cherepanov, A Engelman
Molecular Therapy — Methods & Clinical Development 2014
Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors
M Sokol, M Wabl, IR Ruiz, FS Pedersen
Retrovirology 2014
Genome-Wide Analysis of Alpharetroviral Integration in Human Hematopoietic Stem/Progenitor Cells
A Moiani, JD Suerth, F Gandolfi, E Rizzi, M Severgnini, GD Bellis, A Schambach, F Mavilio
Genes & development 2014
Lentiviral Vectors for Cancer Immunotherapy and Clinical Applications
T Liechtenstein, N Perez-Janices, D Escors
Cancers 2013
Differentiated neuroprogenitor cells incubated with human or canine adenovirus, or lentiviral vectors have distinct transcriptome profiles
S Piersanti, L Astrologo, V Licursi, R Costa, E Roncaglia, A Gennetier, S Ibanes, M Chillon, R Negri, E Tagliafico, EJ Kremer, I Saggio
PloS one 2013
Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy
PB Hackett, DA Largaespada, KC Switzer, LJ Cooper
Translational Research 2013
No Impact of Lentiviral Transduction on Hematopoietic Stem/Progenitor Cell Telomere Length or Gene Expression in the Rhesus Macaque Model
SE Sellers, B Dumitriu, MJ Morgan, WM Hughes, CO Wu, N Raghavarchari, Y Yang, N Uchida, JF Tisdale, DS An, IS Chen, P Hematti, RE Donahue, A LaRochelle, NS Young, RT Calado, CE Dunbar
Molecular Therapy 2013
Biosafety features of lentiviral vectors
A Schambach, D Zychlinski, B Ehrnstrom, C Baum
Human Gene Therapy 2013
Foamy Virus Vectors for HIV Gene Therapy
M Olszko, G Trobridge
Viruses 2013
Cancer gene discovery: exploiting insertional mutagenesis
M Ranzani, S Annunziato, DJ Adams, E Montini
Molecular cancer research : MCR 2013
Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors
A Moiani, A Miccio, E Rizzi, M Severgnini, D Pellin, JD Suerth, C Baum, GD Bellis, F Mavilio
PloS one 2013
Transduction of Fetal Mice With a Feline Lentiviral Vector Induces Liver Tumors Which Exhibit an E2F Activation Signature
R Condiotti, D Goldenberg, H Giladi, T Schnitzer-Perlman, SN Waddington, SM Buckley, D Heim, W Cheung, M Themis, C Coutelle, A Simerzin, E Osejindu, H Wege, M Themis, E Galun
Molecular Therapy 2013
Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy
C Brendel, W Hänseler, V Wohlgensinger, M Bianchi, S Tokmak, L Chen-Wichmann, E Kuzmenko, N Cesarovic, F Nicholls, J Reichenbach, R Seger, M Grez, U Siler
Human Gene Therapy Methods 2013
Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
I Dufait, T Liechtenstein, A Lanna, C Bricogne, R Laranga, A Padella, K Breckpot, D Escors
Scientifica 2012
Development of Gene Therapy for Thalassemia
AW Nienhuis, DA Persons
Cold Spring Harbor Perspectives in Medicine 2012
Gene therapy: too much splice can spoil the dish
D Trono
Journal of Clinical Investigation 2012
Alpharetroviral Vector-mediated Gene Therapy for X-CGD: Functional Correction and Lack of Aberrant Splicing
KB Kaufmann, C Brendel, JD Suerth, U Mueller-Kuller, L Chen-Wichmann, J Schwäble, S Pahujani, H Kunkel, A Schambach, C Baum, M Grez
Molecular Therapy 2012

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
Referenced in 2 patents
132 readers on Mendeley
See more details